Research and Markets (http://www.researchandmarkets.com/research/q9hk8c/drug_device)
has announced the addition of the "Drug
Device Combination Products Market Report 2013 - 2019: Forecasts &
Trends for the $US100 Billion Market" report to their offering.
The global drug device combination products market was valued at USD 66
billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to
2019, to reach an estimated value of USD 115 billion in 2019.
This report studies the global market for drug device combination
products from the perspective of product types. The market is thus
segmented into drug eluting stents, infusion pumps, bone graft implants,
photodynamic therapy, wound care combination devices, inhalers,
transdermal patches and others including intraocular implants and drug
The market for all these product segments is also analyzed for four
major geographic regions, namely North America, Europe, Asia and the
rest of the world (RoW) regions. The markets or all these segments is
analyzed and estimated in USD billion.
Each of the segments have been analyzed on the basis of its current and
future market size for the period 2011 to 2019, in terms of revenue
generation in USD billion, considering 2011 and 2012 as the base years.
The compounded annual growth rate (%CAGR) for each market segment has
been provided for the forecast period 2013 to 2019 along with the
estimations of market size.
A competitive landscape, mapping all the market players and their
respective market shares for 2012, are provided in this report for drug
eluting stents and infusion pumps. A chapter on recommendations for
existing and new entrants is also provided in this report.
Drug Device Combination Products Market:
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Global Drug Device Combination Products, by Type, Size and
Forecast, 2011-2019 (USD Billion)
Chapter 5 Global Drug Device Combination Products, by Geography, 2011 -
2019 (USD Million)
Chapter 6 Competitive Landscape
Chapter 7 Recommendations
Chapter 8 Company Profiles
- Abbott Laboratories
- Alcon, Inc.
- Allergan, Inc.
- Arrow International, Inc.
- Bausch & Lomb, Inc.
- Boston Scientific Corporation
- C.R. Bard, Inc.
- CareFusion Corporation
- Covidien PLC
- Ethicon, Inc.
- Medline Industries, Inc.
- Medtronic, Inc.
- Mylan, Inc.
- Pinnacle Biologics, Inc.
- Stryker Corporation
- Terumo Corporation
- W. L. Gore & Associates, Inc.
For more information visit http://www.researchandmarkets.com/research/q9hk8c/drug_device
[ Back To NFVZone's Homepage ]